SÜDPACK begins PharmaGuard blister capacity expansion in Germany

Core Viewpoint - SÜDPACK is expanding its PharmaGuard blister packaging capacity at its Erolzheim site in Germany, with new facilities expected to be operational by Q3 2027 [1][3]. Group 1: Project Details - The expansion will include new production areas for PharmaGuard, a polypropylene mono-material blister solution for solid-dose applications [1]. - The first stage involves converting an existing hall into an ISO 7-classified cleanroom for GMP-compliant production, which will include a new extrusion line and a slitting machine [2]. - A separate extension will be built to accommodate the site's technical infrastructure and a regranulation facility for plastic waste generated during manufacturing [3]. Group 2: Timeline and Employment Impact - Construction is expected to be completed by June 2026, followed by the installation of production technology, with commissioning targeted for Q3 2027 [3]. - The project is anticipated to create around 50 new jobs when fully operational, with an additional 120 positions expected by 2030 as part of future expansion stages [4]. Group 3: Company Commitment and Community Impact - SÜDPACK's expansion is seen as a significant step for the family-owned group, aligning with its growth and sustainability agenda since its establishment in 1964 [4]. - The Mayor of Erolzheim highlighted SÜDPACK's commitment to Germany as a business location, emphasizing its role as a major employer in the region [5].